Introduction Posttraumatic stress disorder (PTSD) is a prevalent, chronic, and disabling
anxiety disorder that may develop following exposure to a traumatic event. Despite the …

Despite the lack of clinical research, marijuana and synthetic cannabinoids have been
approved to treat posttraumatic stress disorder (PTSD) in several states in the United States …

Post-traumatic stress disorder (PTSD) is a complex disorder that involves dysregulation of
multiple neurobiological systems. The traumatic stressor plays a causal role in producing …

The endocannabinoid system is an increasingly recognised pharmacological target for
treating stress and anxiety disorders, including post-traumatic stress disorder (PTSD) …

Exposure to stress is an undeniable, but in most cases surmountable, part of life. However,
in certain individuals, exposure to severe or cumulative stressors can lead to an array of …

Post-traumatic stress disorder (PTSD) is a psychiatric disorder of significant prevalence and
morbidity, whose pathogenesis relies on paradoxical changes of emotional memory …

The endocannabinoid system plays an important role in the control of emotions, and its
dysregulation has been implicated in several psychiatric disorders. The most common self …

Attentional bias to threat is a key endophenotype that contributes to the chronicity of trauma-
related psychopathology. However, little is known about the neurobiology of this …

The endocannabinoid (eCB) system is one the most ubiquitous signaling systems of the
brain and offers a rich pharmacology including multiple druggable targets. Preclinical …

Endocannabinoids and their attending cannabinoid type 1 (CB 1) receptor have been
implicated in animal models of post-traumatic stress disorder (PTSD). However, their specific …